Maxcyte (MXCT) Shares Outstanding (2020 - 2026)
Maxcyte (MXCT) posted quarterly Shares Outstanding (Entity) of $107.1 million for Q1 2026, up 0.76% year-over-year from $106.3 million in Q1 2025, and little changed quarter-over-quarter from $106.8 million in Q4 2025.
Maxcyte (MXCT) Shares Outstanding (2020 - 2026) Analysis & Trends
Maxcyte (MXCT) has reported Shares Outstanding (Entity) for 7 consecutive years, with $107.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 0.76% year-over-year to $107.1 million; the TTM figure through Mar 2026 stood at $107.1 million (up 0.76% YoY), while the FY2025 annual figure was $106.8 million, up 1.02% from the prior year.
- Shares Outstanding (Entity) held at $107.1 million in Q1 2026 per MXCT's latest filing, from $106.8 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $107.1 million in Q1 2026 and bottomed at $101.5 million in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $104.4 million across 5 years, with a median of $104.4 million in 2024.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) advanced 20.0% — and 2026, when it increased 0.76%.
- Maxcyte's Shares Outstanding (Entity) stood at $102.4 million in 2022, then climbed by 1.53% to $104.0 million in 2023, then grew by 1.68% to $105.7 million in 2024, then increased by 1.02% to $106.8 million in 2025, then climbed by 0.31% to $107.1 million in 2026.
- Business Quant data shows MXCT's Shares Outstanding (Entity) at $107.1 million in Q1 2026, $106.8 million in Q4 2025, and $106.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.37 Bn | 193.76 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 127.75 Bn | 124.27 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 119.07 Bn | 109.85 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.64 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 33.90 Bn | 31.79 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.38 Bn | 23.06 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Maxcyte | 147.42 Mn | 147.42 Mn | 5.60 Mn | 106.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 106.82 Mn |
| Mar 31, 2026 | 106.88 Mn |
| Dec 31, 2025 | 106.43 Mn |
| Sep 30, 2025 | 106.61 Mn |
| Jun 30, 2025 | 106.40 Mn |
| Mar 31, 2025 | 105.95 Mn |
| Dec 31, 2024 | 104.85 Mn |
| Sep 30, 2024 | 105.11 Mn |
| Jun 30, 2024 | 104.64 Mn |
| Mar 31, 2024 | 104.09 Mn |
| Dec 31, 2023 | 103.27 Mn |
| Sep 30, 2023 | 103.45 Mn |
| Jun 30, 2023 | 103.06 Mn |
| Mar 31, 2023 | 102.85 Mn |
| Dec 31, 2022 | 101.70 Mn |
| Sep 30, 2022 | 101.81 Mn |
| Jun 30, 2022 | 101.43 Mn |
| Mar 31, 2022 | 101.31 Mn |
| Dec 31, 2021 | 90.62 Mn |
| Sep 30, 2021 | 84.71 Mn |